The biological and prognostic significance of cell polarity and E- cadherin in grade I infiltrating ductal carcinoma of the breast

Journal of Pathology

Volumn 189, Issue 1, 1999, Pages 20-27

  Tan, D S P ^a   Potts, H W W ^b   Leong, A C K ^a   Gillett, C E ^a   Skilton, D ^a   Harris, W H ^a   Liebmann, R D ^a   Hanby, Andrew M ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Breast carcinoma; E cadherin; Grade; Polarity; Prognosis

Indexed keywords

CELL ADHESION MOLECULE; UVOMORULIN;

ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER SURVIVAL; CELL POLARITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CADHERINS; CARCINOMA, DUCTAL, BREAST; CELL POLARITY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032868566     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199909)189:1<20::AID-PATH394>3.0.CO;2-2     Document Type: Article

References (41)

1. Walker RA, Jones JL, Chappell S, et al. Molecular pathology of breast cancer and its application to clinical management. Cancer Metastasis Rev 1997; 16: 5-27.
2. Elston CW, Ellis O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19: 403-410.
3. Millis RR, Barnes DM, Lampejo OT, et al. Tumour grade does not change between primary and recurrent mammary carcinoma. Eur J Cancer 1998; 34: 548-553.
4. Blamey RW. Phenotypic drift does not happen but lots of interesting things do. Breast 1993; 2: 190.
5. Roylance R, Gorman P, Harris W, et al. Comparative hybridisation of breast tumours stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res 1999; 59: 1433-1436.
6. Molitoris BA, Nelson WJ. Alterations in the establishment and maintenance of epithelial cell polarity as a basis for disease process. J Clin Invest 1990; 85: 3-9.
7. Fish EM, Molitoris BA. Alterations in epithelial polarity and the pathogenesis of disease states. N Engl J Med 1994; 330: 1580-1588.
8. Millis RM. Classification of ductal carcinoma in situ of the breast. Adv Anat Pathol 1996; 3: 114-129.
9. Holland R, Peterse JL, Millis RR, et al. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol 1994; 11: 167-180.
10. Geiger B, Ayalon O. Cadherins. Annu Rev Cell Biol 1992; 8: 307-332.
11. Gumbiner B, McCrea P. Catenins as mediators of the cytoplasmic functions of cadherins. J Cell Sci Suppl 1993; 17: 155-158.
12. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991; 251: 1451-1455.
13. Larue L, Ohsugi M, Hitchenhain J, et al. E-cadherin null mutant embryos fail to form a trophectoderm epithelium. Proc Natl Acad Sci USA 1994; 91: 8263-8267.
14. Drubin DG, Nelson WJ. Origins of cell polarity. Cell 1996; 84: 335-344.
15. Mays RW, Nelson WJ, Marrs JA. Generation of epithelial cell polarity: roles for protein trafficking, membrane-cytoskeleton, and E-cadherin mediated cell adhesion. Cold Spring Harbor Symp Quant Biol 1995; LX: 763-773.
16. Gumbiner B, Stevenson B, Grimaldi A. The role of the cell adhesion molecule uvomorulin in the formation and maintenance of the epithelial junctional complex. J Cell Biol 1988; 107: 1575-1587.
17. Pignatelli M. E-cadherin: a biological marker of tumor differentiation. J Pathol 1993; 171: 81-82.
18. Pignatelli M, Ansari TW, Gunter P, et al. Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade and advanced stage. J Pathol 1994; 174: 243-248.
19. Oka H, Shiozaki H, Kobayashi K, et al. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 1993; 53: 1696-1701.
20. Dorudi S, Sheffield JP, Poulsom R, et al. E-cadherin expression on colorectal carcinoma: an immunocytochemical and in situ hybridisation study. Am J Pathol 1993; 142: 981-986.
21. Nigam A-K, Savage FJ, Boulos PB, et al. Loss of cell-cell and cell-matrix adhesion molecules in colorectal carcinoma. Br J Cancer 1993; 68: 507-514.
22. Bringuier PP, Umbas R, Schaafsma HE, et al. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res 1993; 53: 3241-3245.
23. Mattijsen V, Peters HM, Schalkwijk L, et al. E-cadherin expression in head and neck squamous cell carcinomas is associated with clinical outcome. Int J Cancer 1993; 55: 580-585.
24. Umbas R, Isaacs WB, Bringuier PP, et al. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 1994; 54: 3929-3933.
25. Behrens J, Marcel MM, Van RF, et al. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 1989; 108: 2435-2449.
26. Shimoyama Y, Hirohashi S, Hirano S, et al. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res 1989; 49: 2128-2133.
27. Collet D. Modelling Survival Data in Medical Research. 1st edn. London: Chapman & Hall, 1994.
28. Lipponen P, Saarelainen E, Ji H, et al. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J Pathol 1994; 174: 101-109.
29. Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996; 84: 345-357.
30. Moll R, Mitze M, Frizen U, et al. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 1993; 142: 987-993.
31. Rasbridge SA, Gillet CE, Sampson SA, et al. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol 1993; 169: 245-250.
32. Berx G, Cleton-Jansen AM, Strumane K, et al. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 1996; 13: 1919-1925.
33. Leeuw WJFd, Berx G, Vos CBJ, et al. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 1991; 183: 404-411.
34. Bailey T, Biddlestone L, Shepherd N, et al. Altered cadherin and catenin complexes in the Barren's esophagus-dysplasia-adenocarcinoma sequence. Am J Pathol 1998; 152: 135-144.
35. Becker KF, Atkinson MJ, Reich U, et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994; 54: 3845-3852.
36. Mayer B, Johnson JP, Leitl F, et al. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular differentiation and glandular disintegration. Cancer Res 1993; 53: 1690-1695.
37. Maguire TM, Shering SG, McDermot EW, et al. Assay of E-cadherin by ELISA in human breast cancers. Eur J Cancer 1997; 33: 404-408.
38. Gunji N, Oda T, Todoroki T, et al. Pancreatic carcinoma: correlation between E-cadherin and a-catenin status. Cancer 1997; 82: 1649-1656.
39. Kantak SS, Kramer RH. E-cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells. J Biol Chem 1998; 273: 16953-16961.
40. Hoschuetzky H, Aberle H, Kemler R. Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor. J Cell Biol 1994; 127: 1375-1380.
41. Kanai Y, Ochiai A, Shibata T, et al. c-erbB-2 gene product directly associates with β-catenin and plakoglobin. Biochem Biophys Res Commun 1995; 208: 1067-1072.